Table 4 Comparison of the median concentrations in our study versus NHANES (µg/L).
MA | Study | 2000 | 2005/2006 | 2010 | 2011/2012 | 2013/2014 | 2015/2016 | 2017/2018 | 2019 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
2CyEMA | present study (ESB) | 1.96 | 1.25 | 1.14 | 0.825 | 0.824 | 0.863 | |||
NHANES | 1.88 | 1.78 | 1.69 | 1.48 | 1.44 | |||||
2HEMA | present study (ESB) | 1.22 | 0.661 | 0.665 | 0.699 | 0.727 | 0.568 | |||
NHANES | <LODa | 0.895 | <LODa | <LODa | <LODa | |||||
3HMPMA | present study (ESB) | 119 | 97.5 | 84.3 | 75.8 | 86.0 | 75.9 | |||
NHANES | 231 | 248 | 222 | 248 | 214 | |||||
BzMA | present study (ESB) | 10.5 | 6.97 | 6.90 | 6.17 | 6.42 | 6.01 | |||
NHANES | 6.62 | 6.31 | 6.24 | 6.16 | 5.75 | |||||
PhMA | present study (ESB) | 0.240 | 0.135 | 0.141 | 0.0965 | 0.125 | 0.0910 | |||
NHANES | <LODb | <LODb | <LODb | <LODb | ||||||
2CaEMA | present study (ESB) | 42.3 | 31.4 | 27.9 | 21.2 | 26.4 | 24.2 | |||
NHANES | 56.3 | 45.2 | 45.8 | 51.6 | 51.8 | |||||
2CaHEMA | present study (ESB) | 8.30 | 6.45 | 6.55 | 5.45 | 4.90 | ||||
NHANES | 11.8 | <LODc | <LODc | <LODc | ||||||
MCaMA | present study (ESB) | 104 | 68.9 | 67.5 | 58.4 | 54.9 | 48.4 | |||
NHANES | 150 | 163 | 141 | 145 | 157 | |||||
34HBMA | present study (ESB) | 484 | 382 | 392 | 296 | 328 | 293 | |||
NHANES | 294 | 281 | 267 | 348 | 350 | |||||
2HPMA | present study (ESB) | 17.4 | 13.8 | 13.3 | 11.9 | 15.5 | 12.0 | |||
NHANES | 37.4 | 32.1 | 25.3 | 30.6 | 29.0 | |||||
3HPMA | present study (ESB) | 204 | 152 | 163 | 140 | 144 | 138 | |||
NHANES | 247 | 220 | 210 | 249 | 246 |